|
1
|
Oya M and Kikuchi E: Committee for
Establishment of Clinical Practice Guideline for Management of
Upper Tract Urothelial Carcinoma; Japanese Urological Association:
Evidenced-based clinical practice guideline for upper tract
urothelial carcinoma (summary - Japanese Urological Association,
2014 edition). Int J Urol. 22:3–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gupta R, Paner GP and Amin MB: Neoplasms
of the upper urinary tract: A review with focus on urothelial
carcinoma of the pelvicalyceal system and aspects related to its
diagnosis and reporting. Adv Anat Pathol. 15:127–139. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Colin P, Koenig P, Ouzzane A, Berthon N,
Villers A, Biserte J and Rouprêt M: Environmental factors involved
in carcinogenesis of urothelial cell carcinomas of the upper
urinary tract. BJU Int. 104:1436–1440. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marín-Aguilera M, Mengual L, Ribal MJ,
Musquera M, Ars E, Villavicencio H, Algaba F and Alcaraz A: Utility
of fluorescence in situ hybridization as a non-invasive
technique in the diagnosis of upper urinary tract urothelial
carcinoma. Eur Urol. 51:409–415. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mills IW, Laniado ME and Patel A: The role
of endoscopy in the management of patients with upper urinary tract
transitional cell carcinoma. BJU Int. 87:150–162. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wiener HG, Mian C, Haitel A, Pycha A,
Schatzl G and Marberger M: Can urine bound diagnostic tests replace
cystoscopy in the management of bladder cancer? J Urol.
159:1876–1880. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mian C, Mazzoleni G, Vikoler S, Martini T,
Knüchel-Clark R, Zaak D, Lazica A, Roth S, Mian M and Pycha A:
Fluorescence in situ hybridisation in the diagnosis of upper
urinary tract tumours. Eur Urol. 58:288–292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sobin LH and Wittekind CH: Urological
tumours: Bladder. TNM Classification of Malignant Tumours (6th).
John Wiley & Sons. (Hoboken, NJ). 199–202. 2002.
|
|
9
|
Reynolds JP, Voss JS, Kipp BR, Karnes RJ,
Nassar A, Clayton AC, Henry MR, Sebo TJ, Zhang J and Halling KC:
Comparison of urine cytology and fluorescence in situ
hybridization in upper urothelial tract samples. Cancer Cytopathol.
122:459–467. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo B, Li W, Deng CH, Zheng FF, Sun XZ,
Wang DH and Dai YP: Utility of fluorescence in situ
hybridization in the diagnosis of upper urinary tract urothelial
carcinoma. Cancer Genet Cytogenet. 189:93–97. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
May M, Hakenberg OW, Gunia S, Pohling P,
Helke C, Lübbe L, Nowack R, Siegsmund M and Hoschke B: Comparative
diagnostic value of urine cytology, UBC-ELISA, and fluorescence
in situ hybridization for detection of transitional cell
carcinoma of urinary bladder in routine clinical practice. Urology.
70:449–453. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oosterlinck W, Solona E, van der Meijden
AP, Sylvester R, Böhle A, Rintala E and Lobel B: European
Association of Urology: EAU guidelines on diagnosis and treatment
of upper tract transitional cell carcinnoma. Eur Urol. 46:147–154.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stewart GD, Bariol SV, Grigor KM, Tolley
DA and McNeill SA: A comparison of the pathology of transitional
cell carcinoma of the bladder and upper urinary tract. BJU Int.
95:791–793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Akkad T, Brunner A, Pallwein L, Gozzi C,
Bartsch G, Mikuz G, Steiner H and Verdorfer I: Fluorescence in
situ hybridization for detecting upper urinary tract tumors - a
preliminary report. Urology. 70:753–757. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zincke H, Aguilo JJ, Farrow GM, Utz DC and
Khan AU: Significance of urinary cytology in the early detection of
transitional cell cancer of the upper urinary tract. J Urol.
116:781–783. 1976.PubMed/NCBI
|
|
16
|
Lodde M, Mian C, Wiener H, Haitel A, Pycha
A and Marberger M: Detection of upper urinary tract transitional
cell carcinoma with ImmunoCyt: A preliminary report. Urology.
58:362–366. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang WT, Li LY, Pang J, Ruan XX, Sun QP,
Yang WJ and Gao X: Fluorescence in situ hybridization assay
detects upper urinary tract transitional cell carcinoma in patients
with asymptomatic hematuria and negative urine cytology. Neoplasma.
59:355–360. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song M-J, Lee H-M and Kim S-H: Clinical
usefulness of fluorescence in situ hybridization for
diagnosis and surveillance of bladder cancer. Cancer Genet
Cytogenet. 198:144–150. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shan Z, Wu P, Zheng S, Tan W, Zhou H, Zu
Y, Qi H, Zhang P, Peng H and Wang Y: Evaluation of upper urinary
tract tumors by FISH in Chinese patients. Cancer Genet Cytogenet.
203:238–246. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen AA and Grasso M: Is there a role for
FISH in the management and surveillance of patients with upper
tract transitional-cell carcinoma? J Endourol. 22:1371–1374. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gruschwitz T, Gajda M, Enkelmann A, Grimm
MO, Wunderlich H, Horstmann M and Junker K: FISH analysis of
washing urine from the upper urinary tract for the detection of
urothelial cancers. Int Urol Nephrol. 46:1769–1774. 2014.
|
